• Skip to main content
  • Main Menu
  • Navigation for access to support pages
  • Navigation for access to legal pages
 Logo Viva Technology
  • Session Recordings
  • Speakers
  • Exhibitors
  • FAQ
  • General Public Day
  • confirmation_numberGet Your 2026 Pass
  • Become an Exhibitor
 Viva Technology

17-20 June 2026

Paris Expo Porte de Versailles

1 Place de la Porte de Versailles

F-75015 Paris France

More Infoarrow_right_alt

Event organizers

2025 ThemesConference ProgramOur Speakers

Exhibitors at VivaTech2025 Partners

Startups at VivaTechInvestors at VivaTech2025 Startup Challenges and Awards

JournalistsMedia Partners2025 PresskitPress Releases

About UsOur CommitmentsGeneral Public DayPractical Information

©Viva Technology 2016-2025 all rights reserved

Site MapSite noticeWebsite terms & conditionsB2B terms & conditionsData Privacy
  1.  Logo Viva Technology
  2. Speakers
  3. Jalil Al-Labadi
 Photo Jalil Al-Labadi

Jalil Al-Labadi

CEO

Altibbi

#
Artificial Intelligence
Insurance & Legal
Healthcare & Wellness

About Me

Hello, my name is Jalil. I am the CEO and co-founder at Altibbi which is today the largest digital health platform in the Arab speaking world. I graduated in Industrial Engineering from Bologna, Italy and worked in Pharma before doing my MBA at Thunderbird in the US. I started Altibbi in 2011 and today it gets about 1.5M daily users and 50k primary care telehealth Consultations a month. I am also Schwab Foundation Fellow, a board member at the Royal Health Awareness Socity in Jordan and Winner of the Issam Faris Excellence award from the Middle East Institute in Washington DC.

Hear My Insights

Healthcare for All? Balancing Innovation and Equity Using AI

AI is poised to reshape healthcare, promising to lower costs and expand access through remote monitoring and teleconsultations. Yet, this potential comes with a critical caveat: the risk of exacerbating existing inequalities. Biased datasets and flawed algorithms can perpetuate disparities, disproportionately impacting minority populations and the global south. How can we proactively mitigate AI's risks in healthcare, and what actionable strategies will guarantee equitable access to its benefits?